Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Transmission and prevention news

Show

From To
More people in the UK are starting HIV treatment early, in order to reduce their risk of transmission

There is evidence of increasing interest in HIV treatment as prevention among people living with HIV in the UK, with the number of people starting treatment at

Published
25 March 2015
By
Roger Pebody
Good mental health associated with excellent adherence among people taking ART for prevention

Good mental health was the only significant factor associated with optimal pill-taking among people taking antiretroviral therapy (ART) for the prevention of sexual transmission of HIV,

Published
23 March 2015
By
Michael Carter
Canada: PrEP use now could save considerable sums in the future

A Canadian paper that weighs the cost of using pre-exposure prophylaxis (PrEP) to prevent HIV infections against the lifetime total cost of one HIV infection finds that,

Published
20 March 2015
By
Gus Cairns
Vatican adopts HIV/AIDS treatment model developed in BC

Dr. Montaner said he had a “brief and very pleasant” meeting with the Pope during a “greeting line” at the Vatican on March 11. He also spent several hours with the Catholic church’s equivalent of a minister of health and a minister of justice, who plan to use his method, called treatment as prevention (TasP), in a pilot program that could involve 140,000 patients in Tanzania.

Published
20 March 2015
From
The Globe and Mail
The State of HIV/AIDS Science and Treatment Literacy in the HIV/AIDS Workforce

This survey yields some disturbing findings. Overall, the HIV science and treatment knowledge of the HIV/AIDS workforce is far too low. In many cases, people working in HIV/AIDS appear to doubt the science behind breakthrough biomedical tools for HIV prevention, and far too many members of the workforce are not familiar with many of the bio-medical interventions that will play a critical role in ending the epidemic.

Published
18 March 2015
From
Black AIDS Institute
US: A Near-Failing Science Grade for the Non-Medical HIV Workforce

On average, the survey respondents answered just 63 percent of the questions correctly, including 76 percent of those covering basic knowledge and terminology, 56 percent of the HIV treatment questions, and 46 percent of those on the use of ARVs to prevent transmission of the virus. Only 19 percent of the respondents scored 80 percent or higher on the test.

Published
18 March 2015
From
AIDSMeds
New Model Finds HIV Acute-Phase Infectivity May be Lower Than Previously thought

Previous calculations may have overestimated the importance of HIV transmission from recently infected individuals ("acute-phase infectivity") in driving HIV epidemics, according to an article published by Steve Bellan of the University of Texas at Austin and colleagues in this week's PLOS Medicine. The lower estimates of acute phase infectivity suggest that recently infected individuals--who have not had the chance to start antiretroviral treatment--although still more infectious on average than those in the chronic stage of infection, are not as likely to infect others as was previously thought.

Published
18 March 2015
From
Infection Control Today
When Might Generic Truvada Be Available for PrEP in the US?

Our best guess is that generic Truvada could be available in December 2017, initially produced by Teva, a major generic producer. Two other generic companies, Lupin Pharmaceuticals and Cipla may follow soon after creating competition that can really bring prices down.

Published
17 March 2015
From
Ethan The Blog
Dr. Robert Grant: What Does Ipergay Tell Us About PrEP and ‘Seasons of Risk’?

Much-anticipated efficacy results from a French study of intermittent PrEP were announced at the 2015 Conference on Retroviruses and Opportunistic Infections (CROI) at the end of February. Although PrEP experts do not have enough information from this relatively small study of men to advise or recommend intermittent PrEP use, Ipergay does add to clinical knowledge about one important issue: how to stop using PrEP if it’s no longer needed.

Published
13 March 2015
From
BETA
England government unveils £650k in new HIV spending

The English Government has revealed that £800,000 of new money will be spent on HIV prevention, and to reduce the numbers of late diagnoses. A new £500,000 innovation fund was unveiled, which has been administered by Public Health England (PHE), and will allow small organisations to bid for funding of up to £50,000.

Published
13 March 2015
From
Pink News

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.